Cosman, F.
Gilchrist, N.
McClung, M.
Foldes, J.
de Villiers, T.
Santora, A.
Leung, A.
Samanta, S.
Heyden, N.
McGinnis, J. P. II
Rosenberg, E.
Denker, A. E.
Funding for this research was provided by:
Merck
Article History
Received: 4 June 2015
Accepted: 28 October 2015
First Online: 10 November 2015
Compliance with ethical standards
:
: FC has received consulting, advisory board, and speaker’s bureau fees or honorarium from the study sponsor, Merck & Co. Inc. FC has received consulting, advisory board, and speaker’s bureau fees or honorarium from Amgen, Eli Lilly, Novartis, GSK, Tarsa, Zosano, Pfizer, Unigene, Asahi-Kasei, and Enteris. FC’s Institution has received grants from Merck, Amgen, Eli Lilly, and Novartis.NG has received consultancy fees and speaker’s bureau fees from GGM.MM has received consulting, advisory board, and honorarium from the study sponsor, Merck & Co. Inc. MM has received consulting, advisory board, and honorarium from Amgen and Eli Lilly.JF has received speaker’s bureau fees or honorarium from Merck & Co. Inc. Institution has received grants from the study sponsor, Merck & Co. Inc.TDV has received advisory board, travel support, and speaker’s bureau fees or honorarium from the study sponsor, Merck & Co. Inc. TDV has received advisory board, travel support, and speaker’s bureau fees or honorarium from Adcock Ingram, Servier, Amgen, and Pfizer.Authors AD, NH, AL, ER, SS, JM, and AC are all employees of Merck & Co. Inc and may own stock or stock options.
: This study was funded by Merck & Co. Inc. The study protocol was the responsibility of Merck & Co. Inc. and designed in collaboration with the steering committee composed of the academic authors and various health authorities. All analyses were conducted by scientists at Merck & Co. Inc. All authors had full access to the study data and vouch for the completeness of the data set and the performance of the data analyses. This study was registered with clinicaltrials.gov identifier: with registration number NCT00996801.